ANDRX CORP
15-12G/A, 2000-09-07
PHARMACEUTICAL PREPARATIONS
Previous: ANDRX CORP, 15-12G, 2000-09-07
Next: JDS UNIPHASE CORP /CA/, S-4, 2000-09-07




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 15/A

   CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
      OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
   REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

                                                Commission File Number 000-28454

                                ANDRX CORPORATION
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

    4001 Southwest 47th Avenue, Ft. Lauderdale, Florida 33414 (954) 584-0300
    ------------------------------------------------------------------------
          (Address, including zip code, and telephone number, including
             area code, of registrant's principal executive offices)

                          Common Stock, $.001 par value
            --------------------------------------------------------
            (Title of each class of securities covered by this Form)


                                       N/A
   ---------------------------------------------------------------------------
   (Titles of all other classes of securities for which a duty to file reports
                     under section 13(a) or 15(d) remains)

         Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:

         Rule 12g-4(a)(1)(i)  [X]        Rule 12h-3(b)(1)(i)  [ ]
         Rule 12g-4(a)(1)(ii) [ ]        Rule 12h-3(b)(1)(ii) [ ]
         Rule 12g4-(a)(2)(i)  [ ]        Rule 12h-3(b)(2)(i)  [ ]
         Rule 12g-4(a)(2)(ii) [ ]        Rule 12h-3(b)(2)(ii) [ ]
                                         Rule 15d-6           [ ]

         Approximate number of holders of record as of the certification or
notice date: 1

         Pursuant to the requirements of the Securities Exchange Act of 1934
Andrx Corporation has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.

DATE: September 6, 2000             By: /s/ Scott Lodin
                                        ----------------------------------------
                                        Scott Lodin, Esq., Vice President and
                                        General Counsel



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission